川宁生物：关于中期票据获准注册的公告

Core Points - Chuaning Bio announced the approval of a proposal to issue non-financial corporate debt financing instruments at its board meeting on April 18, 2025, and the annual shareholders' meeting on May 13, 2025 [1] - The company plans to apply for registration to issue various types of debt financing tools, including but not limited to short-term financing bonds, medium-term notes, and super short-term financing bonds, with a total registration amount not exceeding 1 billion yuan for each product type [1] - The company has received a registration acceptance notice from the China Interbank Market Dealers Association, allowing it to register medium-term notes with a total amount of 1 billion yuan, valid for two years from the date of the notice [1] Company Actions - The company will issue medium-term notes with a registration amount of 1 billion yuan, underwritten by Industrial Bank Co., Ltd. [1] - The company can issue medium-term notes in installments during the validity period of the registration and must disclose the issuance results through approved channels [1]